Geiser C F, Bishop Y, Myers M, Jaffe N, Yankee R
Cancer. 1975 Apr;35(4):1027-30. doi: 10.1002/1097-0142(197504)35:4<1027::aid-cncr2820350402>3.0.co;2-9.
The incidence and severity of varicella following a close family contact were evaluated in children with neoplastic diseases who received prophylaxis either with commerical gamma globulin or with zoster immune plasma, as compared to patients who did not receive any prophylaxis. In the untreated group, all 14 patients developed varicella, complicated by 1 case of encephalitis and 2 cases of fatal pneumonia. In the group of 17 patients who received 0.6-1.2 ml/kg body weight of gamma globulin, 16 developed varicella, complicated by pneumonia in 2 cases, with 1 death. In the third group of 27 patients who received 10 ml/kg body weight of zoster immune plasma (ZIP), obtained from healthy adults convalescing from herpes zoster, there were only 8 cases of varicella, all very mild. Thus, prophylaxis with ZIP significantly reduced the incidence of clinical varicella (p less than 0.01) and attenuated the severity of its course.
对接受商业丙种球蛋白或带状疱疹免疫血浆预防治疗的肿瘤疾病患儿,与未接受任何预防治疗的患儿相比,评估其在有密切家庭接触后水痘的发病率和严重程度。在未治疗组中,所有14例患者均患水痘,其中1例并发脑炎,2例并发致命性肺炎。在接受0.6 - 1.2 ml/kg体重丙种球蛋白的17例患者组中,16例患水痘,2例并发肺炎,1例死亡。在第三组27例接受10 ml/kg体重带状疱疹免疫血浆(ZIP)的患者中,ZIP取自患带状疱疹正在康复的健康成年人,仅有8例水痘病例,且均非常轻微。因此,ZIP预防治疗显著降低了临床水痘的发病率(p小于0.01)并减轻了其病程的严重程度。